Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Plant Density, Weed Control Affect Okra Growth, Yield, Profitability and Weed Infestation

August 27, 2026
Continue Reading
plant-density,-weed-control-affect-okra-growth,-yield,-profitability-and-weed-infestation
Posted inBiotechnology

Gene-level RNA sequencing masks widespread transcript-level remodeling during adaptation to hypoxia

August 27, 2026
Continue Reading
gene-level-rna-sequencing-masks-widespread-transcript-level-remodeling-during-adaptation-to-hypoxia
Posted inBiotechnology

Machine Learning and Network Toxicology Reveal Mechanisms of Drug-Induced Reproductive Toxicity

August 27, 2026
Continue Reading
machine-learning-and-network-toxicology-reveal-mechanisms-of-drug-induced-reproductive-toxicity
Posted inBiotechnology

Study examines ethical challenges of medical error disclosure in teaching hospitals

August 27, 2026
Continue Reading
study-examines-ethical-challenges-of-medical-error-disclosure-in-teaching-hospitals
Posted inBiotechnology

RELAX study evaluates EMDR for pain in children with sickle cell disease

August 27, 2026
Continue Reading
relax-study-evaluates-emdr-for-pain-in-children-with-sickle-cell-disease
Posted inBiotechnology

Experts outline management framework for age-related appetite loss after qualitative interviews

August 27, 2026
Continue Reading
experts-outline-management-framework-for-age-related-appetite-loss-after-qualitative-interviews
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

merck’s-hiv-combo-treatment-meets-the-bar-for-viral-suppression-in-pair-of-phase-3-studies
Posted inBiotechnology

Merck’s HIV combo treatment meets the bar for viral suppression in pair of phase 3 studies

December 19, 2024
After hitting the mark in a phase 2 of its investigational islatravir paired with Gilead’s lenacapivir, Merck & Co.'s islatravir…
Read More
vc-firm-pens-$608m-biobucks-deal-to-redirect-ngm’s-mash-drug-to-rare-disease
Posted inBiotechnology

VC firm pens $608M biobucks deal to redirect NGM’s MASH drug to rare disease

December 19, 2024
KdT Ventures has signed off on a $608 million biobucks deal for NGM Biopharmaceuticals’ phase 2-ready metabolic-dysfunction associated steatohepatitis (MASH)…
Read More
scinai-immunotherapeutics-establishes-us.-cdmo-subsidiary
Posted inGenetics

Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary

December 19, 2024
Scinai Immunotherapeutics, which focuses on developing inflammation and immunology biological products and providing CDMO services through its Scinai Bioservices business…
Read More
regeneron-anticoagulant-bests-enoxaparin,-matches-eliquis-in-phase-2-trial
Posted inBiotechnology

Regeneron anticoagulant bests enoxaparin, matches Eliquis in phase 2 trial

December 19, 2024
A pair of Regeneron’s monoclonal antibodies have held their own against a commonly used anticoagulant in a phase 2 trial,…
Read More
vertex’s-pain-trial-hits-endpoint-but-sinks-stock-as-placebo-comparison-spooks-investors
Posted inBiotechnology

Vertex’s pain trial hits endpoint but sinks stock as placebo comparison spooks investors

December 19, 2024
Vertex has reported a phase 2 win that still dented confidence in its pain prospect suzetrigine. The trial linked the near-approval…
Read More
electrocore-to-buy-neurometrix-and-its-quell-fibromyalgia-wearable-stimulator
Posted inMedical Technology

ElectroCore to buy NeuroMetrix and its Quell fibromyalgia wearable stimulator

December 19, 2024
Nerve stimulation company electroCore has signed an agreement to acquire NeuroMetrix and its Quell wearable device aimed at fibromyalgia and…
Read More
uncovering-craniopharyngioma’s-growth-mechanism-may-identify-new-therapy
Posted inGenetics

Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy

December 19, 2024
Craniopharyngioma, a benign yet highly invasive tumor occurring along the hypothalamus-pituitary axis, presents a unique clinical challenge. Although nonmalignant, its…
Read More
former-seagen-ceo’s-biotech-raises-$140m-series-a-to-ready-pd1/vegfr2-antibody-for-clinic
Posted inBiotechnology

Former Seagen CEO’s biotech raises $140M series A to ready PD1/VEGFR2 antibody for clinic

December 19, 2024
Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured "over" $140 million in…
Read More
fda-elevates-boston-scientific-cryoablation-correction-effort-following-four-deaths
Posted inMedical Technology

FDA elevates Boston Scientific cryoablation correction effort following four deaths

December 19, 2024
The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial fibrillation.…
Read More
bms-pays-leqembi-originator-$100m-for-next-gen-preclinical-alzheimer’s-prospects
Posted inBiotechnology

BMS pays Leqembi originator $100M for next-gen preclinical Alzheimer’s prospects

December 19, 2024
Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 million…
Read More

Posts pagination

Previous page 1 … 2,233 2,234 2,235 2,236 2,237 … 2,247 Next page
You May Have Missed
Posted inMedical Technology

FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis

Posted inMedical Technology

Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business

Posted inMedical Technology

Labcorp launches new hepatitis D test to find patients with most severe form of virus

Posted inMedical Technology

Implantica finally nabs FDA approval 8 years after EU green light for reflux implant

Privacy Policy    Terms

Scroll to Top